On October 17, 2022 Galapagos NV (Euronext & NASDAQ: GLPG) reported that it will host its R&D Day 2022 for analysts, investors and financial press on Friday, 4 November 2022 (Press release, Galapagos, OCT 17, 2022, View Source [SID1234622067]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The live event will take place at the Yale Club in New York City from 8:00 am to 10:30 am EDT (13.00 to 15.30 CET). The event will feature presentations by key opinion leaders (KOLs) and management on the company’s strategic objectives, scientific pipeline and commercial progress. The company will also discuss its third quarter financial results, which are scheduled to be published on 3 November 2022.

A live webcast of the event will be accessible through the Investor Center on the company’s website and will be available for replay following the event. Interested parties can register for the webcast utilizing the following link: webcast registration, and participate in the Q&A by telephone conference via the following link: telephone conference registration.